SGFG
TNDM icon

Silver Grove Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Silver Grove Financial Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407 Buy
+27
New +$471 ﹤0.01% 2132

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Silver Grove Financial Group's TNDM Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 27 shares worth $407. The stake represents ﹤0.01% of the portfolio and ranks #2132 among its holdings.

274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Silver Grove Financial Group held 27 shares of Tandem Diabetes Care worth $407 as of Q2 2026.
  • Tandem Diabetes Care was a new Silver Grove Financial Group position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #2132 holding.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.